Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
Shumpei Obata,1 Tomoaki Higashiyama,1 Taku Imamura,1 Masashi Kakinoki,1 Takahide Yanagi,2 Yoshihiro Maruo,2 Masahito Ohji1 1Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan; 2Department of Pediatrics, Shiga University of Medical Science, Otsu, JapanCorrespondence: Shumpe...
Guardado en:
Autores principales: | Obata S, Higashiyama T, Imamura T, Kakinoki M, Yanagi T, Maruo Y, Ohji M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d898a328897644628afeffa2d8aef362 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
por: Majid Abrishami, et al.
Publicado: (2021) -
Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
por: Lin CJ, et al.
Publicado: (2016) -
Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
por: Tsubota K, et al.
Publicado: (2019) -
Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
por: Fouzdar Jain S, et al.
Publicado: (2018) -
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
por: Ribeiro de Carvalho G, et al.
Publicado: (2020)